JP5643011B2 - 生体由来組織、その生産方法及びこれを生産するための装置 - Google Patents
生体由来組織、その生産方法及びこれを生産するための装置 Download PDFInfo
- Publication number
- JP5643011B2 JP5643011B2 JP2010161331A JP2010161331A JP5643011B2 JP 5643011 B2 JP5643011 B2 JP 5643011B2 JP 2010161331 A JP2010161331 A JP 2010161331A JP 2010161331 A JP2010161331 A JP 2010161331A JP 5643011 B2 JP5643011 B2 JP 5643011B2
- Authority
- JP
- Japan
- Prior art keywords
- tissue
- light irradiation
- light
- living body
- biological tissue
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
- 238000004519 manufacturing process Methods 0.000 title claims description 18
- 239000000463 material Substances 0.000 claims description 42
- 239000011347 resin Substances 0.000 claims description 39
- 229920005989 resin Polymers 0.000 claims description 39
- 102000016942 Elastin Human genes 0.000 claims description 20
- 108010014258 Elastin Proteins 0.000 claims description 20
- 229920002549 elastin Polymers 0.000 claims description 20
- 230000001678 irradiating effect Effects 0.000 claims description 10
- 230000015572 biosynthetic process Effects 0.000 claims description 6
- 210000001519 tissue Anatomy 0.000 description 166
- 210000004204 blood vessel Anatomy 0.000 description 16
- 238000000034 method Methods 0.000 description 15
- 102000008186 Collagen Human genes 0.000 description 14
- 108010035532 Collagen Proteins 0.000 description 14
- 229920001436 collagen Polymers 0.000 description 14
- 238000010186 staining Methods 0.000 description 14
- 241001465754 Metazoa Species 0.000 description 11
- 210000004027 cell Anatomy 0.000 description 11
- 210000002808 connective tissue Anatomy 0.000 description 9
- 239000010408 film Substances 0.000 description 8
- 210000004379 membrane Anatomy 0.000 description 8
- 241000282472 Canis lupus familiaris Species 0.000 description 7
- 230000000052 comparative effect Effects 0.000 description 7
- 239000012528 membrane Substances 0.000 description 7
- 210000002950 fibroblast Anatomy 0.000 description 6
- 238000004043 dyeing Methods 0.000 description 5
- DHRLEVQXOMLTIM-UHFFFAOYSA-N phosphoric acid;trioxomolybdenum Chemical compound O=[Mo](=O)=O.O=[Mo](=O)=O.O=[Mo](=O)=O.O=[Mo](=O)=O.O=[Mo](=O)=O.O=[Mo](=O)=O.O=[Mo](=O)=O.O=[Mo](=O)=O.O=[Mo](=O)=O.O=[Mo](=O)=O.O=[Mo](=O)=O.O=[Mo](=O)=O.OP(O)(O)=O DHRLEVQXOMLTIM-UHFFFAOYSA-N 0.000 description 5
- 241000251468 Actinopterygii Species 0.000 description 4
- 241000271566 Aves Species 0.000 description 4
- WZUVPPKBWHMQCE-UHFFFAOYSA-N Haematoxylin Chemical compound C12=CC(O)=C(O)C=C2CC2(O)C1C1=CC=C(O)C(O)=C1OC2 WZUVPPKBWHMQCE-UHFFFAOYSA-N 0.000 description 4
- 241000124008 Mammalia Species 0.000 description 4
- 239000002473 artificial blood Substances 0.000 description 4
- 230000007547 defect Effects 0.000 description 4
- 206010002091 Anaesthesia Diseases 0.000 description 3
- 241000283690 Bos taurus Species 0.000 description 3
- 241000283707 Capra Species 0.000 description 3
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 3
- WSFSSNUMVMOOMR-UHFFFAOYSA-N Formaldehyde Chemical compound O=C WSFSSNUMVMOOMR-UHFFFAOYSA-N 0.000 description 3
- 241000282412 Homo Species 0.000 description 3
- KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 description 3
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 3
- 241001494479 Pecora Species 0.000 description 3
- XUIMIQQOPSSXEZ-UHFFFAOYSA-N Silicon Chemical compound [Si] XUIMIQQOPSSXEZ-UHFFFAOYSA-N 0.000 description 3
- 241000282887 Suidae Species 0.000 description 3
- 230000037005 anaesthesia Effects 0.000 description 3
- 230000003872 anastomosis Effects 0.000 description 3
- 239000012237 artificial material Substances 0.000 description 3
- 238000006243 chemical reaction Methods 0.000 description 3
- 239000000470 constituent Substances 0.000 description 3
- 239000003814 drug Substances 0.000 description 3
- 210000003743 erythrocyte Anatomy 0.000 description 3
- 210000004969 inflammatory cell Anatomy 0.000 description 3
- WABPQHHGFIMREM-UHFFFAOYSA-N lead(0) Chemical compound [Pb] WABPQHHGFIMREM-UHFFFAOYSA-N 0.000 description 3
- 239000013307 optical fiber Substances 0.000 description 3
- 229910052710 silicon Inorganic materials 0.000 description 3
- 239000010703 silicon Substances 0.000 description 3
- 238000002054 transplantation Methods 0.000 description 3
- 238000002689 xenotransplantation Methods 0.000 description 3
- 208000005156 Dehydration Diseases 0.000 description 2
- 238000011316 allogeneic transplantation Methods 0.000 description 2
- 230000018044 dehydration Effects 0.000 description 2
- 238000006297 dehydration reaction Methods 0.000 description 2
- 229940079593 drug Drugs 0.000 description 2
- 230000000694 effects Effects 0.000 description 2
- -1 hyaluronic acid Chemical class 0.000 description 2
- 230000002163 immunogen Effects 0.000 description 2
- 238000002513 implantation Methods 0.000 description 2
- 210000003516 pericardium Anatomy 0.000 description 2
- 102000004169 proteins and genes Human genes 0.000 description 2
- 108090000623 proteins and genes Proteins 0.000 description 2
- 230000008929 regeneration Effects 0.000 description 2
- 238000011069 regeneration method Methods 0.000 description 2
- 239000004065 semiconductor Substances 0.000 description 2
- 238000007447 staining method Methods 0.000 description 2
- 239000000126 substance Substances 0.000 description 2
- 239000010409 thin film Substances 0.000 description 2
- KIUKXJAPPMFGSW-DNGZLQJQSA-N (2S,3S,4S,5R,6R)-6-[(2S,3R,4R,5S,6R)-3-Acetamido-2-[(2S,3S,4R,5R,6R)-6-[(2R,3R,4R,5S,6R)-3-acetamido-2,5-dihydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-2-carboxy-4,5-dihydroxyoxan-3-yl]oxy-5-hydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-3,4,5-trihydroxyoxane-2-carboxylic acid Chemical compound CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@H](O[C@H]2[C@@H]([C@@H](O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@H](O3)C(O)=O)O)[C@H](O)[C@@H](CO)O2)NC(C)=O)[C@@H](C(O)=O)O1 KIUKXJAPPMFGSW-DNGZLQJQSA-N 0.000 description 1
- 239000000592 Artificial Cell Substances 0.000 description 1
- 102000029816 Collagenase Human genes 0.000 description 1
- 108060005980 Collagenase Proteins 0.000 description 1
- 102000004127 Cytokines Human genes 0.000 description 1
- 108090000695 Cytokines Proteins 0.000 description 1
- 102000004190 Enzymes Human genes 0.000 description 1
- 108090000790 Enzymes Proteins 0.000 description 1
- 102000010834 Extracellular Matrix Proteins Human genes 0.000 description 1
- 108010037362 Extracellular Matrix Proteins Proteins 0.000 description 1
- SXRSQZLOMIGNAQ-UHFFFAOYSA-N Glutaraldehyde Chemical compound O=CCCCC=O SXRSQZLOMIGNAQ-UHFFFAOYSA-N 0.000 description 1
- 206010029113 Neovascularisation Diseases 0.000 description 1
- 241000283973 Oryctolagus cuniculus Species 0.000 description 1
- 101710172711 Structural protein Proteins 0.000 description 1
- 239000013543 active substance Substances 0.000 description 1
- 210000004102 animal cell Anatomy 0.000 description 1
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 1
- 210000000013 bile duct Anatomy 0.000 description 1
- 230000017531 blood circulation Effects 0.000 description 1
- 239000002775 capsule Substances 0.000 description 1
- 150000001720 carbohydrates Chemical class 0.000 description 1
- 238000004113 cell culture Methods 0.000 description 1
- 230000010261 cell growth Effects 0.000 description 1
- 229960002424 collagenase Drugs 0.000 description 1
- 210000004087 cornea Anatomy 0.000 description 1
- 238000012937 correction Methods 0.000 description 1
- 230000002950 deficient Effects 0.000 description 1
- 238000001647 drug administration Methods 0.000 description 1
- 210000001951 dura mater Anatomy 0.000 description 1
- 241001233061 earthworms Species 0.000 description 1
- 210000002889 endothelial cell Anatomy 0.000 description 1
- 229940088598 enzyme Drugs 0.000 description 1
- 210000002744 extracellular matrix Anatomy 0.000 description 1
- 210000001035 gastrointestinal tract Anatomy 0.000 description 1
- 230000012010 growth Effects 0.000 description 1
- 239000003102 growth factor Substances 0.000 description 1
- 229910052736 halogen Inorganic materials 0.000 description 1
- 150000002367 halogens Chemical class 0.000 description 1
- 210000003709 heart valve Anatomy 0.000 description 1
- 229920002674 hyaluronan Polymers 0.000 description 1
- 229960003160 hyaluronic acid Drugs 0.000 description 1
- 238000001727 in vivo Methods 0.000 description 1
- 210000001365 lymphatic vessel Anatomy 0.000 description 1
- 239000000025 natural resin Substances 0.000 description 1
- 235000015097 nutrients Nutrition 0.000 description 1
- 210000000056 organ Anatomy 0.000 description 1
- 239000003960 organic solvent Substances 0.000 description 1
- 238000013021 overheating Methods 0.000 description 1
- 210000003101 oviduct Anatomy 0.000 description 1
- 229910052760 oxygen Inorganic materials 0.000 description 1
- 239000001301 oxygen Substances 0.000 description 1
- 238000010248 power generation Methods 0.000 description 1
- 230000001737 promoting effect Effects 0.000 description 1
- 230000001172 regenerating effect Effects 0.000 description 1
- 238000007789 sealing Methods 0.000 description 1
- 210000003491 skin Anatomy 0.000 description 1
- 210000000329 smooth muscle myocyte Anatomy 0.000 description 1
- 210000000130 stem cell Anatomy 0.000 description 1
- 230000001954 sterilising effect Effects 0.000 description 1
- 238000004659 sterilization and disinfection Methods 0.000 description 1
- 238000007920 subcutaneous administration Methods 0.000 description 1
- 239000000758 substrate Substances 0.000 description 1
- 239000002344 surface layer Substances 0.000 description 1
- 239000004094 surface-active agent Substances 0.000 description 1
- 229920003002 synthetic resin Polymers 0.000 description 1
- 239000000057 synthetic resin Substances 0.000 description 1
- 238000009210 therapy by ultrasound Methods 0.000 description 1
- 210000003437 trachea Anatomy 0.000 description 1
- 210000000626 ureter Anatomy 0.000 description 1
- 230000002792 vascular Effects 0.000 description 1
- 210000002073 venous valve Anatomy 0.000 description 1
- 238000005406 washing Methods 0.000 description 1
- 230000037303 wrinkles Effects 0.000 description 1
Landscapes
- Prostheses (AREA)
Description
2 エラスチン
3 毛細血管
4 光照射手段
5 駆動電源
6 生体由来組織製造装置
7 光源
8 樹脂製構造体
9 リードフレーム
10 リード線
11 内腔面
12 内膜部
13 中膜部
14 外膜部
15 赤血球
16 炎症細胞
17 繊維芽細胞
Claims (8)
- 生体組織材料の存在する環境下で光照射手段により光照射を行うことにより、前記光照射手段の周囲に新たに形成され、かつ、人体の一部を構成している組織を除く生体由来組織であって、毛細血管あるいはエラスチンが形成されたことを特徴とする生体由来組織。
- 生体組織材料の存在する環境下で光照射手段により光照射を行うことにより、前記光照射手段の周囲に新たに形成され、かつ、人体の一部を構成している組織を除く生体由来組織であって、毛細血管およびエラスチンが形成されたことを特徴とする生体由来組織。
- 前記光照射手段は、波長530nm以下の光を含んでいる光源であることを特徴とする請求項1又は2に記載の生体由来組織。
- 前記生体由来組織は、膜状組織、弁状組織、管状組織のいずれかである請求項1〜3のいずれかに記載の生体由来組織。
- 人体を除く生体組織材料の存在する環境下で光照射手段により光照射を行うことにより、前記光照射手段の周囲に毛細血管あるいはエラスチンを含んだ新たな組織体を形成することを特徴とする生体由来組織の生産方法。
- 透光性を有する樹脂製構造体に前記光照射手段を埋設し、該樹脂製構造体を通して光照射を行うことにより、樹脂製構造体の周囲に前記組織体を形成することを特徴とする請求項5に記載の生体由来組織の生産方法。
- 生体組織材料の存在する環境下で照射を行う光照射手段を備え、該光照射手段の周囲に新たな組織体を形成することを特徴とする生体由来組織生産装置。
- 前記光照射手段の光源は、透光性を有する樹脂製構造体内に埋設されていることを特徴とする請求項7に記載の生体由来組織生産装置。
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2010161331A JP5643011B2 (ja) | 2010-07-16 | 2010-07-16 | 生体由来組織、その生産方法及びこれを生産するための装置 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2010161331A JP5643011B2 (ja) | 2010-07-16 | 2010-07-16 | 生体由来組織、その生産方法及びこれを生産するための装置 |
Publications (3)
Publication Number | Publication Date |
---|---|
JP2012020031A JP2012020031A (ja) | 2012-02-02 |
JP2012020031A5 JP2012020031A5 (ja) | 2013-08-29 |
JP5643011B2 true JP5643011B2 (ja) | 2014-12-17 |
Family
ID=45774816
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2010161331A Expired - Fee Related JP5643011B2 (ja) | 2010-07-16 | 2010-07-16 | 生体由来組織、その生産方法及びこれを生産するための装置 |
Country Status (1)
Country | Link |
---|---|
JP (1) | JP5643011B2 (ja) |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2014030598A (ja) * | 2012-08-03 | 2014-02-20 | Shinkan Kogyo Kk | 膜状結合組織体形成用基材及びこれを用いた膜状結合組織体の生産方法 |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4837379A (en) * | 1988-06-02 | 1989-06-06 | Organogenesis Inc. | Fibrin-collagen tissue equivalents and methods for preparation thereof |
US6663659B2 (en) * | 2000-01-13 | 2003-12-16 | Mcdaniel David H. | Method and apparatus for the photomodulation of living cells |
WO2005118013A1 (ja) * | 2004-06-01 | 2005-12-15 | Dai Nippon Printing Co., Ltd. | 人工血管およびその製造方法 |
JP2007068878A (ja) * | 2005-09-09 | 2007-03-22 | National Cardiovascular Center | 組織体の製造方法及び生体埋入物 |
-
2010
- 2010-07-16 JP JP2010161331A patent/JP5643011B2/ja not_active Expired - Fee Related
Also Published As
Publication number | Publication date |
---|---|
JP2012020031A (ja) | 2012-02-02 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
McInnes et al. | Preparation and use of decellularized extracellular matrix for tissue engineering | |
ES2685638T3 (es) | Carne comestible producida artificialmente | |
CN1289259A (zh) | 缔合有生长因子的假体 | |
US20120015331A1 (en) | Scaffold | |
CN1713861A (zh) | 血管化增强的移植构造物 | |
KR20100046037A (ko) | 생체 내에서 유강장기 또는 유강장기의 일부분의 재생을 증진하기 위한 보철기구 | |
CN1512856A (zh) | 作为色素上皮移植基底的显微构建组织 | |
CN100531806C (zh) | 羊膜基质覆膜血管内支架及制备方法 | |
Casarin et al. | Tissue engineering and regenerative medicine in pediatric urology: urethral and urinary bladder reconstruction | |
US11179505B2 (en) | Methods for stabilizing collagen-containing tissue products against enzymatic degradation | |
Chu et al. | Dynamic multiphoton imaging of acellular dermal matrix scaffolds seeded with mesenchymal stem cells in diabetic wound healing | |
Vaghela et al. | Microvascular development in the rat arteriovenous loop model in vivo—A step by step intravital microscopy analysis | |
Liu et al. | Evaluation of the effect of 3D‐bioprinted gingival fibroblast‐encapsulated ADM scaffolds on keratinized gingival augmentation | |
JP2019529015A (ja) | 生着率を増加させた移植用真皮層及びその製造方法 | |
Kim et al. | Non‐invasive in vivo monitoring of transplanted stem cells in 3D‐bioprinted constructs using near‐infrared fluorescent imaging | |
JP5643011B2 (ja) | 生体由来組織、その生産方法及びこれを生産するための装置 | |
JP2012135406A (ja) | 生体由来組織形成基材、これを用いた生体由来組織の生産方法及び生体由来組織 | |
JPWO2018211877A1 (ja) | 糸及びその製造方法 | |
JP2011025002A (ja) | 弁付人工血管及び弁付人工血管用柱状芯基材並びに弁付人工血管の製造方法 | |
JP2014030598A (ja) | 膜状結合組織体形成用基材及びこれを用いた膜状結合組織体の生産方法 | |
JP2016136984A (ja) | 管状組織体形成基材 | |
JP5658008B2 (ja) | 弁付き人工血管形成用基材、これを用いた弁付き人工血管の生産方法及び弁付き人工血管 | |
KR102073353B1 (ko) | Led를 이용한 어류의 피부 상처 치료 방법 | |
Oie et al. | In-body optical stimulation formed connective tissue vascular grafts,“biotubes,” with many capillaries and elastic fibers | |
KR20220115589A (ko) | 조직 재생 다중-약물 칵테일 및 이를 전달하기 위한 장치 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A521 | Written amendment |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20130711 |
|
A621 | Written request for application examination |
Free format text: JAPANESE INTERMEDIATE CODE: A621 Effective date: 20130711 |
|
A521 | Written amendment |
Free format text: JAPANESE INTERMEDIATE CODE: A821 Effective date: 20130711 |
|
A977 | Report on retrieval |
Free format text: JAPANESE INTERMEDIATE CODE: A971007 Effective date: 20140314 |
|
A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20140318 |
|
A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20140527 |
|
A521 | Written amendment |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20140703 |
|
A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20140826 |
|
A521 | Written amendment |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20140916 |
|
TRDD | Decision of grant or rejection written | ||
A01 | Written decision to grant a patent or to grant a registration (utility model) |
Free format text: JAPANESE INTERMEDIATE CODE: A01 Effective date: 20141014 |
|
A61 | First payment of annual fees (during grant procedure) |
Free format text: JAPANESE INTERMEDIATE CODE: A61 Effective date: 20141030 |
|
R150 | Certificate of patent or registration of utility model |
Ref document number: 5643011 Country of ref document: JP Free format text: JAPANESE INTERMEDIATE CODE: R150 |
|
S533 | Written request for registration of change of name |
Free format text: JAPANESE INTERMEDIATE CODE: R313533 |
|
R350 | Written notification of registration of transfer |
Free format text: JAPANESE INTERMEDIATE CODE: R350 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
S531 | Written request for registration of change of domicile |
Free format text: JAPANESE INTERMEDIATE CODE: R313531 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R350 | Written notification of registration of transfer |
Free format text: JAPANESE INTERMEDIATE CODE: R350 |
|
LAPS | Cancellation because of no payment of annual fees |